New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line

New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Acetylcholinesterase (AChE) inhibitors constitute a pharmacotherapeutic strategy for AD treatment. Resveratrol has anti-inflammatory, neuroprotective, anticarcinogenic, and antioxidant properties. This study aimed to evaluate t...

Full description

Bibliographic Details
Main Authors: Martina Donozo, Valeria Cavallaro, Carlos Javier Baier, Ana Paula Murray
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Medical Sciences Forum
Subjects:
resveratrol
Alzheimer’s disease
acetylcholinesterase
SH-SY5Y cells
reactive oxygen species
Online Access:https://www.mdpi.com/2673-9992/21/1/31

Internet

https://www.mdpi.com/2673-9992/21/1/31

Similar Items